methoxyhydroxyphenylglycol has been researched along with Supranuclear Palsy, Progressive in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujii, S; Hatanaka, Y; Yamamoto, M | 1 |
| Kohira, I; Ogasawara, N; Ogawa, N; Ujike, H; Yamamoto, M | 1 |
2 other study(ies) available for methoxyhydroxyphenylglycol and Supranuclear Palsy, Progressive
| Article | Year |
|---|---|
Result of long-term administration of L-threo-3,4-dihydroxyphenylserine in patients with pure akinesia as an early symptom of progressive supranuclear palsy.
Topics: Antiparkinson Agents; Droxidopa; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Movement Disorders; Supranuclear Palsy, Progressive | 1997 |
[CSF monoamine metabolites in patients with progressive supranuclear palsy].
Topics: Aged; Biogenic Monoamines; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Supranuclear Palsy, Progressive | 1992 |